K08670903

Kromasil^® Eternity^™ C18 高效液相色谱柱

5 μm particle size, pore size 100 Å, L × I.D. 250 mm × 4.6 mm

• 同義詞: Kromasil C18
• 分類程式碼代碼: 41115700
• eCl@ss: 32110501
• NACRES: SB.52

屬性

• agency: suitable for USP L1
• 產品線: Kromasil^®
• 製造商／商標名: Kromasil^® ET-5-C18-4.6X250
• 存貨情形: available only in USA, Canada and Puerto Rico
• 標籤範圍: 14% Carbon loading
• 技術: HPLC: suitable
• 長度 × 內徑: 250 mm × 4.6 mm
• 表面積: 330 m²/g
• 基質活性組: C18 (octadecyl) phase
• 粒徑: 5 μm
• 孔徑: 100 Å
• pH值範圍: 1-12
• 應用: food and beverages
• 分離技術: reversed phase

描述

應用

• Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.: This study developed and validated an HPLC-MS/MS method for determining clopidogrel in human plasma. The Kromasil^® Eternity C18 HPLC column was employed to achieve the separation. This method was shown to be efficient, precise, and suitable for pharmacokinetic studies (Liu et al., 2016).


• Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe.: The study focused on developing a stability-indicating assay method for atorvastatin and ezetimibe using UPLC. The Kromasil^® Eternity C18 HPLC column was critical in achieving the required resolution and sensitivity, demonstrating its role in stability studies of pharmaceutical combinations (Goel et al., 2013).

法律資訊

Eternity is a trademark of EKA Chemicals AB

Kromasil is a registered trademark of EKA Chemicals AB